Prudential Financial
GYRE icon

Prudential Financial’s Gyre Therapeutics GYRE Stock Holding History

Prudential Financial’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,720
Closed -$10K – 2648
2022
Q3 		$10K Hold
2,720
– – ﹤0.01% 2642
2022
Q2 		$36K Buy
+2,720
New +$18.1K ﹤0.01% 2591
2014
Q2 		– Sell
-26
Closed -$99K – 2442
2014
Q1 		$99K Sell
26
-1
-4% -$3.7K ﹤0.01% 2212
2013
Q4 		$87K Sell
27
-1
-4% -$3.94K ﹤0.01% 2238
2013
Q3 		$118K Sell
28
-2
-7% -$8.05K ﹤0.01% 2212
2013
Q2 		$99K Buy
+30
New +$114K ﹤0.01% 2221

Other funds holding GYRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Prudential Financial's GYRE Position: Q4 2022 in Review

Prudential Financial sold out of Gyre Therapeutics (GYRE) in Q4 2022, closing a stake of 2,720 shares — an estimated $10K sold.

Prudential Financial first reported a position in GYRE in Q2 2013 and held it in 6 quarters. The position peaked at $118K in Q3 2013. 34 funds tracked by Wall St. Rank hold GYRE as of Q4 2022.

  • Prudential Financial reported no remaining Gyre Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 2,720 Gyre Therapeutics shares in Q4 2022, an estimated $10K.
  • Prudential Financial first reported a position in Gyre Therapeutics in Q2 2013 and held it in 6 quarters.
  • Prudential Financial's Gyre Therapeutics position peaked at $118K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.